Journal of advanced lung health
http://jscholaronline.org/journals/journal-of-lung-diseases-and-pulmonary-medicine/ NettetTo search for articles by type, specialty or year of publication, please use Advanced Search features. Keyword. separated by space. Author Name. separated by comma …
Journal of advanced lung health
Did you know?
Nettet8. sep. 2024 · Raena Rhone, PharmD Medical Science Liaison, Neurology at Bristol Myers Squibb Nettet30. nov. 2024 · Special Issue "Innate Immunity Orchestration in Lung Health and Diseases". A special issue of Biomedicines (ISSN 2227-9059). This special issue …
NettetBackground: Numeracy is one's ability to use numbers in context and influence's decision making and perceptions of health risk. Worry about lung cancer is an indicator of perceived risk (PR) and is related to interest in cessation and cancer screening. Purpose: The analysis sought to explore underlying relationships among worry about lung … Nettet13. apr. 2024 · Triple-negative breast cancer (TNBC) is the most aggressive and lethal breast cancer (BC) subtype. 1 Chemotherapy still represents the backbone of the first-line treatment for patients with advanced TNBC (aTNBC). In patients with programmed death-ligand 1 (PD-L1)-negative aTNBC, single-agent or combination chemotherapy …
Nettet20. feb. 2024 · Background: Lung cancer is the leading cause of cancer-related death in the United States, with the majority of lung cancer occurrence diagnosed after the … NettetBackground: Asthma is a chronic inflammatory disease of the airways common in children. Soluble advanced glycation end-product receptor (sRAGE) is a blood biomarker of lung damage and inflammation. We sought to determine whether it could also be a biomarker in childhood asthma. Methods: We conducted a prospective, observational, analytical …
NettetManuscripts do not need to tell a complete story but must be compelling, innovative, and novel. The manuscript should not exceed 4,000 words, including references and figure …
Nettet22. jan. 2024 · Lung cancer treatment varies according to pathology stage and the patient’s fitness for various treatments. Currently, there are three main treatment modalities; surgery, radiotherapy, and systemic therapies (including chemotherapy, molecular targeted therapies and immunotherapy). right mainstem intubationNettetAim: Healthcare administrative databases represent a valuable source for real-life data analysis. The primary aim of this study is to compare effectiveness and cost profile in non-small-cell lung cancer (NSCLC) patients harboring synchronous brain metastases (BMs) who received non-chemo first-line systemic therapy with or without advanced … right mainstem bronchus occlusionNettetBreast Cancer Gastrointestinal Cancer Genitourinary Cancer Gynecologic Cancer Head and Neck Cancer Hematologic Malignancies Melanoma Molecular Testing and Biomarkers Neurooncology Patient and Survivor Care Supportive Care … right maintenance box